Quick answer: Continuous glucose monitor (CGM) claims are denied most often because of documentation gaps, not coding mistakes. Missing or outdated records, supplier changes mid-therapy, and poor handoffs between prescribers and suppliers trigger Medicare denials. A denial-resistant workflow verifies what is already on file and confirms documentation before every claim.

A patient switches CGM suppliers mid-therapy. The new supplier assumes the base receiver is already on file with Medicare, the patient has been on CGM therapy over a year, why wouldn't it be? It isn't. The claim comes back denied for missing proof of beneficiary-owned equipment, on a device the patient has used without interruption. Nothing about the patient's eligibility changed. A handoff did.

That's the pattern behind most CGM denials, and it's why CGM claims deserve their own line item in a denial-prevention strategy, not a footnote under general DME. On paper, a CGM claim looks simple, one HCPCS code for the receiver, one for the supply allowance, a couple of modifiers. In practice, it's one of the more unforgiving corners of DME reimbursement, because small documentation misses trigger full denials, not partial payment.

Denial rates have been climbing industry-wide for years, and more of that increase traces to documentation gaps than to genuine medical necessity disputes. CGM billing sits squarely in that trend, its documentation requirements are specific, and easy to miss.

Why CGM Billing Behaves Differently

Most DME categories require a written order and a diagnosis supporting medical necessity. CGM billing asks for that, plus ongoing proof of use. Under Medicare's Glucose Monitors LCD (L33822) and its Policy Article (A52464), the initial approval isn't the end of the story, every six months, the record needs an in-person or Medicare-approved telehealth visit confirming the beneficiary's adherence to the CGM and diabetes regimen. Miss that visit, or document it vaguely, and the supply claims tied to it become vulnerable, even though the original device approval was never in question.

CGM devices also carry a coding verification layer most DME doesn't. Every device billed under E2102 or E2103 must be listed under that code on the PDAC's Product Classification List (PCL). If it isn't, the claim denies as incorrect coding, no matter how clean the rest of the claim is.

Then there's enrollment, only suppliers enrolled in the Medicare DMEPOS program can bill CGM supply allowances (A4238/A4239). Practices that have billed other DME under their standard Part B number sometimes learn this only after a denial.

So a CGM claim needs everything a standard DME claim needs, plus a recurring adherence visit, a verified device-to-code match, and the right supplier enrollment.

The Gaps That Actually Trigger Denials

  • No standard written order on file: The SWO must reach the supplier before the claim is submitted, or it denies as not reasonable and necessary. Orders commonly get delayed in EHR routing, signed after the claim already went out, or filed under the wrong encounter.

  • Missing proof of beneficiary-owned equipment: Supply claims (A4238/A4239) need evidence the base receiver is already on file, either in Medicare's claims history or as a narrative on the claim stating ownership and approximate purchase date. Without it, the claim denies for missing the equipment that requires the supply. This is the scenario above, most common when a patient switches CGM models or suppliers mid-therapy.

  • The six-month visit note goes uncaptured: This is the most underestimated gap, because it isn't one-and-done, it recurs for the life of the claim relationship, and practices lose track of when the clock resets per patient. It gets worse in fragmented care, if the payer expects adherence documentation from the physician managing the overall diabetes regimen, and that's a PCP who hasn't seen the patient in eight months while a specialist has, the claim denies on a timing issue that looks like a medical necessity failure on the surface.

  • Modifier errors: Under Policy Article A52464, KX for insulin-treated beneficiaries, KS for non-insulin-treated (never both on one line), CG once LCD criteria are met, KF for FDA Class III receivers. A common failure, a patient's insulin status changes, or a device gets reclassified, and the billing template doesn't catch up.

  • Device-to-code mismatch: Billing E2102 or E2103 for a device not listed under that code on the PCL is a coding error, not a documentation one, it usually means resubmitting under the correct code, not filing a correction. This happens when product lines change or staff pull a code from an outdated crosswalk.

  • Missing-equipment remark never corrected: Even after a denial for missing ownership evidence, the supplier still has to submit that information for Medicare to file before the claim can be reprocessed. Without a standing workflow for this, practices get re-denied on the same issue, sometimes repeatedly.

Most of these aren't failures of clinical judgment. They happen when intake, clinical documentation, and billing run as separate systems with no shared checklist.

What It's Costing RCM Teams

A mid-size endocrinology practice managing 300 CGM patients on monthly supply billing generates roughly 3,600 supply claims a year. A 5% denial rate means 180 denied claims annually. At $75 per claim to rework, that's $13,500 in labor, before counting the cash flow drag of delayed reimbursement. On one avoidable documentation category.

The trend explains why that math keeps getting worse, clinical and documentation-related denials, the bucket CGM failures fall into, are a growing share of total denials industry-wide, and missing or inaccurate claim data is consistently cited as a top driver.

A missing SWO, ownership narrative, or visit note is a paperwork problem with a known fix, unlike a true medical necessity denial. These aren't unbeatable. Most organizations just don't have a process to catch them before submission, or to work them consistently after.

Where the Breakdown Starts

The failure point is rarely the biller. It's upstream, in the handoffs between intake, clinical documentation, and coding:

  • Intake and order capture: SWOs get signed but aren't routed to billing in a structured way, so claims go out ahead of the paperwork.

  • Clinical documentation: The six-month visit happens, but the note doesn't explicitly tie adherence to medical necessity, and a payer reads it differently than intended.

  • Coding and device matching: Staff bill from memory or an outdated crosswalk instead of checking the current PCL after a device change.

  • Claims scrubbing: Generic DME scrubbers catch missing modifiers but rarely carry CGM-specific logic, so claims that pass still deny downstream.

Fixing any one in isolation helps a little. Fixing the handoffs is where the recovery happens.

Building a Denial-Resistant Workflow

  • Track the six-month clock per patient, not per claim. A recertification calendar visible to both clinical and billing staff catches the adherence requirement before it becomes a denial.

  • Validate the PCL match at order entry, not at claim submission, a quick check when the order is placed saves weeks of rework later.

  • Standardize the ownership narrative with a required intake field, so it's never missing at claim time.

  • Build CGM-specific scrubbing logic, separate from generic DME rules, KX/KS exclusivity, CG eligibility, KF for Class III devices.

  • Route every RFI and missing-documentation denial to a single owner who resubmits with the correction, instead of letting it sit.

  • Audit a sample of CGM claims quarterly against the current LCD and Policy Article, since coverage rules change more often than billing manuals get reviewed.

None of this needs new headcount. It needs CGM claims to have their own workflow instead of living inside generic DME.

How QWay Healthcare Closes the Gap

QWay Healthcare's coding and billing specialists validate the SWO, the PCL device match, and the modifier combination before a CGM claim leaves the building, rather than waiting for it to bounce back with an RFI. QWay also tracks the recurring six-month recertification most in-house teams lose visibility on, and owns resubmission for anything that slips through, so documentation gaps stop becoming permanent write-offs. For RCM leaders deciding whether to fix this internally or bring in a partner who knows the LCD line by line, that upfront validation is usually where the fastest return shows up.

Frequently Asked Questions

What's the most common reason CGM claims get denied?

Missing documentation, not clinical ineligibility, no SWO, no six-month adherence visit note, a device billed under the wrong PCL-listed code, or missing DMEPOS enrollment for supply claims.

How often is the six-month documentation requirement due?

Every six months, tied to a visit confirming adherence to the CGM and diabetes regimen.

Can a coding denial be corrected, or does it need full resubmission?

Full resubmission under the correct code. A PCL mismatch is a coding error, not something a simple correction fixes.

Do KX and KS ever go on the same line?

No, KX is insulin-treated, KS is non-insulin-treated, and they're mutually exclusive. Billing both is a common, avoidable rejection cause.

External References